These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 10342324

  • 1. Contribution of CD40-CD154-mediated costimulation to an alloresponse in vivo.
    Förster E, Krenger W, Joergensen J, Hof R, Geha RS, Holländer GA.
    Transplantation; 1999 May 15; 67(9):1284-7. PubMed ID: 10342324
    [Abstract] [Full Text] [Related]

  • 2. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K, Schönbeck U, Mach F, Libby P, Mitchell RN.
    J Immunol; 2000 Sep 15; 165(6):3506-18. PubMed ID: 10975872
    [Abstract] [Full Text] [Related]

  • 3. Dependency of direct pathway CD4+ T cells on CD40-CD154 costimulation is determined by nature and microenvironment of primary contact with alloantigen.
    van Maurik A, Fazekas de St Groth B, Wood KJ, Jones ND.
    J Immunol; 2004 Feb 15; 172(4):2163-70. PubMed ID: 14764682
    [Abstract] [Full Text] [Related]

  • 4. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner.
    Iwakoshi NN, Mordes JP, Markees TG, Phillips NE, Rossini AA, Greiner DL.
    J Immunol; 2000 Jan 01; 164(1):512-21. PubMed ID: 10605049
    [Abstract] [Full Text] [Related]

  • 5. Absence of allograft ICAM-1 attenuates alloantigen-specific T cell priming, but not primed T cell trafficking into the graft, to mediate acute rejection.
    Zhang QW, Kish DD, Fairchild RL.
    J Immunol; 2003 Jun 01; 170(11):5530-7. PubMed ID: 12759430
    [Abstract] [Full Text] [Related]

  • 6. Allograft rejection by primed/memory CD8+ T cells is CD154 blockade resistant: therapeutic implications for sensitized transplant recipients.
    Zhai Y, Meng L, Gao F, Busuttil RW, Kupiec-Weglinski JW.
    J Immunol; 2002 Oct 15; 169(8):4667-73. PubMed ID: 12370407
    [Abstract] [Full Text] [Related]

  • 7. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival.
    Lu L, Li W, Fu F, Chambers FG, Qian S, Fung JJ, Thomson AW.
    Transplantation; 1997 Dec 27; 64(12):1808-15. PubMed ID: 9422424
    [Abstract] [Full Text] [Related]

  • 8. CD40-gp39 interactions play a critical role during allograft rejection. Suppression of allograft rejection by blockade of the CD40-gp39 pathway.
    Larsen CP, Alexander DZ, Hollenbaugh D, Elwood ET, Ritchie SC, Aruffo A, Hendrix R, Pearson TC.
    Transplantation; 1996 Jan 15; 61(1):4-9. PubMed ID: 8560571
    [Abstract] [Full Text] [Related]

  • 9. Prolonged blockade of CD40-CD40 ligand interactions by gene transfer of CD40Ig results in long-term heart allograft survival and donor-specific hyporesponsiveness, but does not prevent chronic rejection.
    Guillot C, Guillonneau C, Mathieu P, Gerdes CA, Ménoret S, Braudeau C, Tesson L, Renaudin K, Castro MG, Löwenstein PR, Anegon I.
    J Immunol; 2002 Feb 15; 168(4):1600-9. PubMed ID: 11823487
    [Abstract] [Full Text] [Related]

  • 10. CD40 signaling replaces CD4+ lymphocytes and its blocking prevents chronic rejection of heart transplants.
    Fischbein MP, Ardehali A, Yun J, Schoenberger S, Laks H, Irie Y, Dempsey P, Cheng G, Fishbein MC, Bonavida B.
    J Immunol; 2000 Dec 15; 165(12):7316-22. PubMed ID: 11120867
    [Abstract] [Full Text] [Related]

  • 11. Monoclonal antibody treatment to prolong the secondary cardiac allograft survival in alloantigen-primed mice.
    Xie B, Chen J, Wang F, Lan T, Wang Y, Xia J, Li Z, Xie Q, Huang R, Qi Z.
    Scand J Immunol; 2010 May 15; 71(5):345-52. PubMed ID: 20500685
    [Abstract] [Full Text] [Related]

  • 12. Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection.
    Hancock WW, Sayegh MH, Zheng XG, Peach R, Linsley PS, Turka LA.
    Proc Natl Acad Sci U S A; 1996 Nov 26; 93(24):13967-72. PubMed ID: 8943044
    [Abstract] [Full Text] [Related]

  • 13. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
    Lu L, Li W, Zhong C, Qian S, Fung JJ, Thomson AW, Starzl TE.
    Transplantation; 1999 Sep 27; 68(6):747-57. PubMed ID: 10515374
    [Abstract] [Full Text] [Related]

  • 14. Memory alloreactive B cells and alloantibodies prevent anti-CD154-mediated allograft acceptance.
    Burns AM, Ma L, Li Y, Yin D, Shen J, Xu J, Chong AS.
    J Immunol; 2009 Feb 01; 182(3):1314-24. PubMed ID: 19155477
    [Abstract] [Full Text] [Related]

  • 15. Analysis of the CD40 and CD28 pathways on alloimmune responses by CD4+ T cells in vivo.
    Bingaman AW, Ha J, Durham MM, Waitze SY, Tucker-Burden C, Cowan SR, Pearson TC, Larsen CP.
    Transplantation; 2001 Oct 15; 72(7):1286-92. PubMed ID: 11602857
    [Abstract] [Full Text] [Related]

  • 16. CD8+CD122+PD-1+ Tregs Synergize With Costimulatory Blockade of CD40/CD154, but Not B7/CD28, to Prolong Murine Allograft Survival.
    Liu H, Qiu F, Wang Y, Zeng Q, Liu C, Chen Y, Liang CL, Zhang Q, Han L, Dai Z.
    Front Immunol; 2019 Oct 15; 10():306. PubMed ID: 30863408
    [Abstract] [Full Text] [Related]

  • 17. The role of the CD40 pathway in alloantigen-induced hyporesponsiveness in vivo.
    Niimi M, Pearson TC, Larsen CP, Alexander DZ, Hollenbaugh D, Aruffo A, Linsley PS, Thomas E, Campbell K, Fanslow WC, Geha RS, Morris PJ, Wood KJ.
    J Immunol; 1998 Nov 15; 161(10):5331-7. PubMed ID: 9820506
    [Abstract] [Full Text] [Related]

  • 18. Genetic characterization of strain differences in the ability to mediate CD40/CD28-independent rejection of skin allografts.
    Williams MA, Trambley J, Ha J, Adams AB, Durham MM, Rees P, Cowan SR, Pearson TC, Larsen CP.
    J Immunol; 2000 Dec 15; 165(12):6849-57. PubMed ID: 11120808
    [Abstract] [Full Text] [Related]

  • 19. Cutting edge: CD4+CD25+ alloantigen-specific immunoregulatory cells that can prevent CD8+ T cell-mediated graft rejection: implications for anti-CD154 immunotherapy.
    van Maurik Av, Herber M, Wood KJ, Jones ND.
    J Immunol; 2002 Nov 15; 169(10):5401-4. PubMed ID: 12421913
    [Abstract] [Full Text] [Related]

  • 20. Rejection of mouse cardiac allografts by costimulation in trans.
    Mandelbrot DA, Kishimoto K, Auchincloss H, Sharpe AH, Sayegh MH.
    J Immunol; 2001 Aug 01; 167(3):1174-8. PubMed ID: 11466331
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.